Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
BMJ Supportive & Palliative Care|March 20, 2014
Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phaseEefje M Sizoo, Johan A F Koekkoek, Tjeerd J Postma, et al.
Neuro-Oncology Practice|October 13, 2025
End-of-life care in patients with glioblastoma after early advance care planningLara Fritz, Esther Zaloumis, Hanneke Zwinkels, et al.
NMR in Biomedicine|January 29, 2025
Extension of T2 Hyperintense Areas in Patients With a Glioma: A Comparison Between High-Quality 7 T MRI and Clinical ScansBárbara Schmitz-Abecassis, Ivo Cornelissen, Robin Jacobs, et al.
Neuro-Oncology Practice|November 17, 2022
Advance care planning (ACP) in glioblastoma patients: Evaluation of a disease-specific ACP program and impact on outcomesLara Fritz, Marthe C M Peeters, Hanneke Zwinkels, et al.
Epilepsia|March 18, 2021
First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acidPim B van der Meer, Linda Dirven, Marta Fiocco, et al.
Neurology|October 11, 2022
Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort StudyPim B van der Meer, Linda Dirven, Marta Fiocco, et al.
Journal of Neuro-Oncology|July 1, 2021
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamideMark P van Opijnen, Pim B van der Meer, Linda Dirven, et al.
Neuro-Oncology Practice|January 8, 2025
Symptom management in isocitrate dehydrogenase mutant gliomaTobias Walbert, Edward K Avila, Florien W Boele, et al.
Journal of Neuro-Oncology|September 27, 2023
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational studyPim B van der Meer, Linda Dirven, Marta Fiocco, et al.
Pageof 8